New drug cocktail targets tough breast cancer
NCT ID NCT05230810
First seen Mar 22, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tests a combination of two targeted drugs, tucatinib and alpelisib, in about 40 adults with a specific type of advanced breast cancer (HER2-positive with a PIK3CA mutation). The goal is to see if the combo is safe and can slow or stop tumor growth. Participants take both pills by mouth, and the study tracks side effects and how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Care & Hematology-Fort Collins
Fort Collins, Colorado, 80528, United States
-
Louisiana State University Health Sciences Center
New Orleans, Louisiana, 70112, United States
-
University of Colorado Cancer Center
Aurora, Colorado, 80045, United States
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.